Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aditya Hegde, Bangalore G. Kalyani, Shyam Sundar Arumugham, Janardhanan C. Narayanaswamy, Suresh Bada Math & Y. C. Janardhan Reddy. (2017) Aripiprazole augmentation in highly treatment-resistant obsessive–compulsive disorder – experience from a specialty clinic in India . International Journal of Psychiatry in Clinical Practice 21:1, pages 67-69.
Read now
Read now
Hidehiro Umehara, Shusuke Numata, Makoto Kinoshita, Shinya Watanabe, Shutaro Nakaaki, Satsuki Sumitani & Tetsuro Ohmori. (2016) No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population. Neuropsychiatric Disease and Treatment 12, pages 611-615.
Read now
Read now
Mariana Pizarro, Leonardo F Fontenelle, Daniel C Paravidino, Murat Yücel, Eurípedes C Miguel & Gabriela B de Menezes. (2014) An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder. Expert Opinion on Pharmacotherapy 15:10, pages 1391-1401.
Read now
Read now
Shyam Sundar Arumugham & YC Janardhan Reddy. (2014) Commonly asked questions in the treatment of obsessive-compulsive disorder. Expert Review of Neurotherapeutics 14:2, pages 151-163.
Read now
Read now
Articles from other publishers (43)
Mohan Gautam. (2023) Clinical Recommendations for Augmentation Agents in Obsessive-Compulsive Disorder Partially Responsive to Serotonin Reuptake Inhibitors. Journal of Clinical Psychopharmacology 43:4, pages 369-377.
Crossref
Crossref
Rituparna Maiti, Archana Mishra, Anand Srinivasan & Biswa Ranjan Mishra. (2023) Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis. Acta Psychiatrica Scandinavica.
Crossref
Crossref
Asif Ahmad Bhat, Gaurav Gupta, Obaid Afzal, Imran Kazmi, Fahad A. Al-Abbasi, Abdulmalik Saleh Alfawaz Altamimi, Waleed Hassan Almalki, Sami I. Alzarea, Sachin Kumar Singh & Kamal Dua. (2023) Neuropharmacological effect of risperidone: From chemistry to medicine. Chemico-Biological Interactions 369, pages 110296.
Crossref
Crossref
Madhuri H. Nanjundaswamy, Lavanya P. Sharma & Shyam Sundar Arumugham. 2023. Handbook of Cognitive Behavioral Therapy by Disorder. Handbook of Cognitive Behavioral Therapy by Disorder
205
217
.
Sujita Kumar Kar & Vikas Menon. (2021) Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view. CNS Spectrums 27:5, pages 530-532.
Crossref
Crossref
Harsh Pathak, Swarna Buddha Nayok, Logesh Kanakaraj, Himanshu Ghanghoriya, Vanteemar S. Sreeraj, Shivarama Varambally & Ganesan Venkatasubramanian. (2022) Accelerated HD-tDCS for rapid response in treatment-resistant obsessive-compulsive disorder: A case report. Brain Stimulation 15:5, pages 1091-1092.
Crossref
Crossref
Jennie M. Kuckertz, Richard J. McNally, Bradley C. Riemann, Claudia Van Borkulo, Benjamin W. Bellet, Jason W. Krompinger, Nathaniel Van Kirk & Martha J. Falkenstein. (2022) Does the network structure of obsessive-compulsive symptoms at treatment admission identify patients at risk for non-response?. Behaviour Research and Therapy 156, pages 104151.
Crossref
Crossref
Hanife Olbrich, Ina Jahn, Katarina Stengler, Erich Seifritz & Michael Colla. (2022) Heart rate variability in obsessive compulsive disorder in comparison to healthy controls and as predictor of treatment response. Clinical Neurophysiology 138, pages 123-131.
Crossref
Crossref
Shahla Akouchakian, Mohammad Javad Tarrahi & Elham Mohebati. (2021) Evaluation of Clonidine Augmentation Therapy for Obsessive-Compulsive Disorder Treatment; a Randomized Clinical Trial. Iranian Journal of Psychiatry and Behavioral Sciences 15:3.
Crossref
Crossref
Bernhard Weidle, Tord Ivarsson, Fernando R. Asbahr, Rosa Calvo, David Mataix-Cols, Moira A. Rynn & Eric A. Storch. (2021) Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder. Psychiatry Research 299, pages 113858.
Crossref
Crossref
Markian Pazuniak & Scott R. Pekrul. (2020) Obsessive–Compulsive Disorder in Autism Spectrum Disorder Across the Lifespan. Psychiatric Clinics of North America 43:4, pages 745-758.
Crossref
Crossref
Gulen Guler Aksu, Pinar Akdere Dogdu, Pelin Dag, Meryem Ozlem Kutuk & Fevziye Toros. (2020) Safe and Effective Use of Venlafaxine, Mirtazapine, and Aripiprazole in an Adolescent with Treatment-Resistant Obsessive-Compulsive Disorder. Psychiatric Annals 50:11, pages 509-512.
Crossref
Crossref
Madhuri H. Nanjundaswamy, Shyam Sundar Arumugham, Janardhanan C. Narayanaswamy & Y.C. Janardhan Reddy. (2020) A prospective study of intensive in-patient treatment for obsessive-compulsive disorder. Psychiatry Research 291, pages 113303.
Crossref
Crossref
Iris Sijercic, Kristen M. Whitfield, Stephanie E. Cassin & Martin M. Antony. (2020) A systematic review of cognitive-behavioral therapy for pharmacotherapy treatment-resistant obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders 26, pages 100532.
Crossref
Crossref
Ali TalaeiFarhad Farid HosseiniZahra AghiliShahin AkhondzadehElham AsadpourNeema John MehramizFatemeh Forouzanfar. (2020) A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Canadian Journal of Physiology and Pharmacology 98:4, pages 236-242.
Crossref
Crossref
Markian Pazuniak & Scott R. Pekrul. (2020) Obsessive–Compulsive Disorder in Autism Spectrum Disorder Across the Lifespan. Child and Adolescent Psychiatric Clinics of North America 29:2, pages 419-432.
Crossref
Crossref
Sujita Kumar Kar, Suyash Dwivedi & Vivek Agarwal. (2019) Relevance of extended protocol and maintenance TMS in obsessive-compulsive disorder: A case report. Asian Journal of Psychiatry 42, pages 32-33.
Crossref
Crossref
Dong-Dong Zhou, Xiao-Xin Zhou, Yao Li, Kai-Fu Zhang, Zhen Lv, Xiao-Rong Chen, Li-Yang Wan, Wo Wang, Gao-Mao Wang, Da-Qi Li, Ming Ai & Li Kuang. (2019) Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 90, pages 277-287.
Crossref
Crossref
Leonardo F. Fontenelle & Murat Yücel. 2018. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena. A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena
1
13
.
Srinivas Balachander, Prabhath Gujjadi Kodancha, Shyam Sundar Arumugham, Jaisoorya T. Sekharan, Janardhanan C. Narayanaswamy & YC Janardhan Reddy. (2019) Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor–Resistant Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 39:1, pages 82-85.
Crossref
Crossref
Rachel Middleton, Michael G. Wheaton, Reilly Kayser & H. Blair Simpson. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
165
177
.
Michael H. Bloch. 2018. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder
329
356
.
Tord Ivarsson, Gudmundur Skarphedinsson & Bernhard Weidle. 2018. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder. The Clinician's Guide to Cognitive-Behavioral Therapy for Childhood Obsessive-compulsive Disorder
155
183
.
Ulku Akyol Ardic, Eyup Sabri Ercan, Ayse Kutlu, Deniz Yuce, Melis Ipci & Sevim Berrin Inci. (2016) Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood. Child Psychiatry & Human Development 48:5, pages 699-704.
Crossref
Crossref
Robert Hudak, Xenia Borue & Mehak Sharma. 2017. The Wiley Handbook of Obsessive Compulsive Disorders. The Wiley Handbook of Obsessive Compulsive Disorders
1039
1060
.
Bangalore G. Kalyani, Aditya Hegde, Shyam Sundar Arumugham, Janardhanan C. Narayanaswamy, Suresh Bada Math & Y.C. Janardhan Reddy. (2017) Is Ondansetron Augmentation Effective in Obsessive-Compulsive Disorder?. Journal of Clinical Psychopharmacology 37:3, pages 380-381.
Crossref
Crossref
Isaac Zike, Tim Xu, Natalie Hong & Jeremy Veenstra-VanderWeele. (2017) Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology. Neuroscience 345, pages 256-273.
Crossref
Crossref
Daniel Rutrick, Dan J. Stein, Ganesan Subramanian, Brian Smith, Maurizio Fava, Gregor Hasler, Jang-Ho Cha, Fabrizio Gasparini, Toni Donchev, Magdalena Ocwieja, Donald Johns & Baltazar Gomez-Mancilla. (2017) Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study. Advances in Therapy 34:2, pages 524-541.
Crossref
Crossref
YC Janardhan Reddy, AShyam Sundar, JanardhananC Narayanaswamy & SureshBada Math. (2017) Clinical practice guidelines for Obsessive-Compulsive Disorder. Indian Journal of Psychiatry 59:5, pages 74.
Crossref
Crossref
Aditya Hegde, Bangalore G. Kalyani, Shyam Sundar Arumugham, Janardhanan C. Narayanaswamy, Suresh Bada Math & Y.C. Janardhan Reddy. (2016) Effectiveness of Risperidone Augmentation in Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 36:4, pages 381-384.
Crossref
Crossref
Joseph Bergman, Chanoch Miodownik, Paul P. Lerner, Einat Miodownik, Alexander Shulkin & Vladimir Lerner. (2016) Donepezil as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case Series. Clinical Neuropharmacology 39:4, pages 194-196.
Crossref
Crossref
Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Akira Nishi, Masahito Nakataki, Issei Imoto, Satsuki Sumitani & Tetsuro Ohmori. (2016) Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder. PLOS ONE 11:6, pages e0157232.
Crossref
Crossref
Antonio Bruno, Gianluca Pandolfo, Clemente Cedro, Giuseppa Gallo, Mariangela De Felice, Rocco A. Zoccali & Maria Rosaria A. Muscatello. (2016) Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder. Clinical Neuropharmacology 39:1, pages 6-9.
Crossref
Crossref
Tanya K. Murphy, S. Evelyn Stewart & Demian Obregon. 2016. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
169
193
.
Adam M. Reid, Joseph P.H. McNamara, Tanya K. Murphy, Andrew G. Guzick, Eric A. Storch, Gary R. Geffken & Regina Bussing. (2015) Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. Journal of Psychiatric Research 71, pages 140-147.
Crossref
Crossref
Gudmundur Skarphedinsson & Tord Ivarsson. (2015) Evidence-Based Treatments in Treatment-Naïve and Treatment-Resistant Pediatric Obsessive-Compulsive Disorder. Current Behavioral Neuroscience Reports 2:3, pages 127-136.
Crossref
Crossref
Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Shutaro Nakaaki, Issei Imoto, Satsuki Sumitani & Tetsuro Ohmori. (2015) No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population. Human Psychopharmacology: Clinical and Experimental 30:5, pages 372-376.
Crossref
Crossref
Xenia Borue, Mehak Sharma & Robert Hudak. (2015) Biological treatments for obsessive-compulsive and related disorders. Journal of Obsessive-Compulsive and Related Disorders 6, pages 7-26.
Crossref
Crossref
Phillip J. Seibell, Rebecca J. Hamblin & Eric Hollander. (2015) Obsessive-Compulsive Disorder: Overview and Standard Treatment Strategies. Psychiatric Annals 45:6, pages 297-302.
Crossref
Crossref
Yu-Jie Chiou, Pao-Yen Lin & Yu Lee. (2015) Risperidone as Monotherapy for a Patient With Obsessive Compulsive Disorder Comorbid With Schizoaffective Disorder. Clinical Neuropharmacology 38:3, pages 114-116.
Crossref
Crossref
Michael H. Bloch & Eric A. Storch. (2015) Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children. Journal of the American Academy of Child & Adolescent Psychiatry 54:4, pages 251-262.
Crossref
Crossref
Kemal Utku YaziciIpek Percinel. (2014)
The Role of Glutamatergic Dysfunction in Treatment-Resistant Obsessive-Compulsive Disorder: Treatment of an Adolescent Case with
N
-Acetylcysteine Augmentation
. Journal of Child and Adolescent Psychopharmacology 24:9, pages 525-527.
Crossref
Crossref
Catherine Kariuki-Nyuthe, Baltazar Gomez-Mancilla & Dan J. Stein. (2014) Obsessive compulsive disorder and the glutamatergic system. Current Opinion in Psychiatry 27:1, pages 32-37.
Crossref
Crossref